Sign in / Join Now
ETFs & Funds
It's been a jading experience with $
, coupled with finishing Goldacre's book, Bad Pharma, I can't really trust anything biotech now
Not to mention the absurdity of $
, legality notwithstanding.
Add a reply...
Latest StockTalks »
people get CYTR breaking news and analysis by email alert.
Get email alerts on CYTR »
Get latest price
From other sites
Leading Sarcoma Expert Dr. Earl W. Brien Joins CytRx Board Of Directors
at TheStreet (Fri, 9:00AM)
CytRx CEO Pockets Millions of Dollars as Failed Sarcoma Drug Moves to FDA
at TheStreet (Tue, 8:59AM)
CytRx Presents Positive Interim Results From On-going Phase 1b/2 Aldoxorubicin Combination Clinical Trial At The 2016 CTOS Annual Meeting
at TheStreet (Nov 11, 2016)
CytRx Presents Interim Results From On-going Aldoxorubicin Plus Ifosfamide/Mesna Combination Clinical Trial At ESMO 2016 Congress
at TheStreet (Oct 10, 2016)
24-Hour Deadline Alert: Law Offices Of Howard G. Smith Reminds Investors Of The Upcoming September 23rd Deadline In The Class Action Lawsuit Against CytRx Corporation
at TheStreet (Sep 22, 2016)